The Food and Drug Administration (FDA) conducted an inspection of Advanced Generic Corporation in Miami on March 23, according to data posted on the FDA’s website.
The scope of the inspection included:
- Food Composition, Standards, Labeling and Econ
- Foodborne Biological Hazards
The FDA’s final report concluded that Advanced Generic Corporation was not required to take action to address its managing operations.
The FDA conducts routine inspections of facilities nationwide to ensure workplaces and products comply with laws and regulations aimed at improving public health. Findings from inspections are made publicly available.
The agency’s website states that the FDA is the federal entity tasked with overseeing the safety and quality of human and animal drugs, biological items, medical products and tobacco.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
